Ampio Pharmaceuticals, Inc. filed its 10-K on Mar 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, Moss Adams LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 USD | -18.52% | -8.52% | -89.27% |
15/04 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
27/03 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-89.27% | 250K | |
+6.54% | 111B | |
+10.92% | 106B | |
-12.93% | 22.24B | |
+0.38% | 21.25B | |
-4.45% | 18.97B | |
-37.85% | 18.52B | |
-10.62% | 16.81B | |
+38.96% | 12.54B | |
-25.42% | 8.09B |
- Stock Market
- Equities
- AMPE Stock
- News Ampio Pharmaceuticals, Inc.
- Ampio Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt